Literature DB >> 16534434

Menopause knowledge and subjective experience among peri- and postmenopausal women with bipolar disorder, schizophrenia and major depression.

Martha Sajatovic1, Susan Hatters Friedman, Isabel N Schuermeyer, Roknedin Safavi, Rosalinda V Ignacio, Robert W Hays, Jane A West, Frederic C Blow.   

Abstract

This study examined concerns regarding menopause among women with schizophrenia/schizoaffective disorder (N = 30), women with bipolar disorder (N = 25), and women with major depression (N = 36). The three groups were compared regarding knowledge of menopause, expectations of effect of menopause, and menopause-related quality of life. All women had deficits in fund of knowledge regarding menopause. More than half (53.8%) agreed that they felt more stressed due to menopause or approaching menopause, and 51.6% felt that menopause has had a negative effect on their emotional state. Perceptions of menopause effect on emotional states between the three groups were similar. The top five symptoms experienced by women with serious mental illness were all problems related to psychological issues: feeling depressed (88%, N = 80), feeling anxious (88%, N = 80), feeling tired or worn out (87%, N = 79), feeling a lack of energy (86%, N = 78), and experiencing poor memory (84%, N = 76). Larger-scale studies evaluating the effects of menopause on serious mental illness are needed to clarify how menopause affects illness outcomes in women with serious mental illness.

Entities:  

Mesh:

Year:  2006        PMID: 16534434     DOI: 10.1097/01.nmd.0000202479.00623.86

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  5 in total

1.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 2.  Impact of menstrual cycle events on bipolar disorder course: a narrative review of current evidence.

Authors:  Elena Aragno; Andrea Fagiolini; Alessandro Cuomo; Elena Paschetta; Giuseppe Maina; Gianluca Rosso
Journal:  Arch Womens Ment Health       Date:  2022-03-02       Impact factor: 3.633

3.  The Phytoestrogen Genistein Produces Similar Effects as 17β-Estradiol on Anxiety-Like Behavior in Rats at 12 Weeks after Ovariectomy.

Authors:  Juan Francisco Rodríguez-Landa; Jonathan Cueto-Escobedo; Abraham Puga-Olguín; Eduardo Rivadeneyra-Domínguez; Blandina Bernal-Morales; Emma Virginia Herrera-Huerta; Andrea Santos-Torres
Journal:  Biomed Res Int       Date:  2017-10-31       Impact factor: 3.411

Review 4.  Hormonal Agents for the Treatment of Depression Associated with the Menopause.

Authors:  Megan Herson; Jayashri Kulkarni
Journal:  Drugs Aging       Date:  2022-07-30       Impact factor: 4.271

5.  Risk of Psychiatric Disorders Following Symptomatic Menopausal Transition: A Nationwide Population-Based Retrospective Cohort Study.

Authors:  Li-Yu Hu; Cheng-Che Shen; Jeng-Hsiu Hung; Pan-Ming Chen; Chun-Hsien Wen; Yung-Yen Chiang; Ti Lu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.